Our Mission
Our values-driven approach gives us access to the unique investment opportunities and expertise that enable Paladin to deliver on its commitment to its investors.
Paladin’s mission is to enhance the security, resiliency and safety of free and open societies by supporting the development of vitally important technologies. The companies we back help commercial enterprises and governments to defend their operations and national security goals, and provide solutions to personal privacy, safety and health.
Our Strategy
Paladin’s core strength is identifying, supporting, investing in and exiting innovative global early stage and growth companies that develop promising technologies to address the critical cyber, AI and advanced technological needs of both commercial and government customers.
For more than two decades, our mission-driven approach has enabled us to be a trusted partner to investors, entrepreneurs and governments. We have developed powerful investment principles and commitments that are being adopted across the cyber and secure AI investment community.
Our success is driven by our ability to identify and execute investments in new, compelling innovations as an early entrant. This includes emerging areas like digital biology and safety tech, where human behavior and traditional industry are converging in our digital environments.
How it works
Our strength is our people. Paladin’s investment process is built on themes and theses identified by our team of strategic advisers, who draw on their global ecosystems to identify technologies of absolute need. Paladin’s information advantage leads to disciplined due diligence and investment selection, enabling us to create value for our investors.
Cyber, AI & Deep Tech
We are living in a digital-first society. Advancing, sustaining and defending our critical infrastructure requires both innovation and investment.
Digital resilience requires dual use solutions across an ecosystem of cyber, AI and deep tech, a $4.6 trillion market.
Digital Biology & Biosecurity
Digital Biology represents the future of bioscience—where new products and pharmaceuticals are engineered, not discovered. Increasingly powered by advances in artificial intelligence, it includes industries like genomic analysis and editing, synthetic biology, bio-based products, and regenerative medicine.
Investment Principles and Commitments
As new cyber and artificial intelligence digital platforms and technologies are created by the innovation and investment engines of the globe, it is important to be guided by a set of voluntary investment principles and commitments.